EcoR I/Hind III End Modification Kit from Novagen
Silencer CellReady siRNA Transfection Optimization Kit from Ambion
SUPERaseIn from Ambion
...ly and negatively supercoiled DNA in presence of E...percoiling on transcription in vitro , Studying c...e degree of supercoiling of naturally occurring DN...th by only one base-pair , Increasing restriction...
Biology Products:(Date:12/2/2009)...ke their first cigarette within minutes after waki...oduct of nicotine when processed by the body, than... of cigarettes smoked. , "Since cotinine leve...results suggest that smokers who smoke immediately...ancer," said researcher Joshua E. Muscat, Ph.D., M...
(Date:12/2/2009)...condhand smoke for a prolonged period of time and ...ancer, even in women who never smoked cigarettes t...to side-stream smoke could increase risk of breast...nolds, Ph.D., senior research scientist at the Nor..."While no single epidemiologic study can answer th...
(Date:12/2/2009)...moky Mountain forest,s woodland herb population ha... understories recover from logging, according to P...ng in portions of the forest nearly 80 years ago, ...ry forest floor was similar to that of undisturbed...sor of forestry and natural resources, said that c...
Breaking Biology News(10 mins):Increased nicotine levels detected in those who light-up earlier 2Exposure to secondhand cigarette smoke over a lifetime increased breast cancer risk later in life 2Study finds logging effects vary based on a forest's history, climate 2Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 1Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 2Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 3Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 4Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 5Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 6Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 7NATB Announces Partnership With Ronald McDonald House Charities 28R 29 53932 1NATB Announces Partnership With Ronald McDonald House Charities 28R 29 53932 2NATB Announces Partnership With Ronald McDonald House Charities 28R 29 53932 3Viral Genetics Creates Subsidiary to Develop Cancer Therapy 13443 1Viral Genetics Creates Subsidiary to Develop Cancer Therapy 13443 2Viral Genetics Creates Subsidiary to Develop Cancer Therapy 13443 3Viral Genetics Creates Subsidiary to Develop Cancer Therapy 13443 4(Date:12/4/2009)...if., Dec. 4 BlueFire Eth...pany focused on changing the world,s transportatio...from non-food cellulosic wastes, has been ranked n...Hottest Companies in Bioenergy;" the company,s sec... voters rank BlueFire Ethanol among the top 20 bio...
(Date:12/3/2009)... Dec. 3 ACCESS PHARMAC...ay provided an update on its European commercial l...l mucositis, a debilitating side effect of radiati...lly launched by Access, partner, SpePharm, in six ...ly, Norway, Greece and Sweden. Access is conductin...
(Date:12/3/2009)...alif., Dec. 3 Peregrine ...nced that it will release its financial results fo...er 10, 2009 at 7:00 a.m. EST and will host a confe...1:30 a.m. EST on the same day. ,, Peregrine,s s...r the second quarter ended October 31, 2009 and wi...
(Date:12/3/2009)...EW DELHI, India, Dec. 3 /PRNewswire-Asia/ -- Dr. S...Shenzhen Beike Biotechnology Co. Ltd.,( http://www...h-Risk Diabetic,Foot Care in New Delhi, India, Nov... research and regenerative medicine company. ,,...atry Association (IPA), aimed,to help podiatrists ...
Breaking Biology Technology:BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 2BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 3BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 4Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4Peregrine Pharmaceuticals to Report Second Quarter FY 2010 Financial Results 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3